S. 935 · 118th Congress (2023–2025)
Fair Accountability and Innovative Research Drug Pricing Act of 2023
This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month.
Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug. Manufacturers are subject to civil penalties for failing to comply with the bill's requirements. Additionally, the Food and Drug Administration must post the information on its website.
Show official title
A bill to require reporting regarding certain drug price increases, and for other purposes.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 935’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Tammy Baldwin (D-WI)
- Cosponsors
3 cosponsors
2 original · 1 later
- Sen. Mike Braun (R-IN)· Original · Mar 22, 2023
- Sen. Tina Smith (D-MN)· Original · Mar 22, 2023
- Sen. Martin Heinrich (D-NM)· Later · Apr 30, 2024
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
Fair Accountability and Innovative Research Drug Pricing Act of 2023
Display title, Short title · Introduced in Senate
A bill to require reporting regarding certain drug price increases, and for other purposes.
Official title · Introduced in Senate